Stock Events

Stock Events

Kalbe Farma Tbk PT 

$8.69
102
+$0.00+0% Thursday 20:00

Statistics

Day High
8.79
Day Low
8.5
52W High
18.59
52W Low
8.25
Volume
6,546
Avg. Volume
319
Mkt Cap
406.81B
P/E Ratio
9.43
Dividend Yield
2.56%
Dividend
0.22

Upcoming

14
JUL
Dividend Payment
Decreased
 
7
JUN 27
Dividend Ex
Estimated
 
16
JUL 27
Dividend Payment
Estimated
 
5
JUN 28
Dividend Ex
Estimated
 
14
JUL 28
Dividend Payment
Estimated
 

Dividends

2.56%Dividend Yield
Jul 26
$0.22
Jul 25
$0.44
Jul 24
$0.38
Jun 23
$0.51
Jul 22
$0.47
10Y Growth
-2.56%
5Y Growth
-10.38%
3Y Growth
-24.12%
1Y Growth
-49.62%

Earnings

24JulExpected
Q2 2024
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
0
0
0
0
Expected EPS
0.001068035024
Actual EPS
N/A

Financials

9.91%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
4.06BRevenue
402.77MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PTKFY. It's not an investment recommendation.
Alamtri Resources Indonesia Tbk PT
24
ADRO.JK
Bank Rakyat Indonesia (Persero) Tbk PT
20
BBRI.JK
Bukit Asam (Persero) Tbk PT
19
PTBA.JK
Bank Central Asia Tbk PT
19
BBCA.JK

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Sociedad Quimica Y Minera de Chile.
SQM
Mkt Cap20.77B
Sociedad Química y Minera is a global supplier of plant nutrients and chemicals, competing in the nutrition and health market.
Pfizer
PFE
Mkt Cap138.61B
Pfizer is a global pharmaceutical giant, competing in various healthcare sectors including those where Kalbe Farma operates.
Merck
MRK
Mkt Cap319.99B
Merck & Co., Inc. is a global healthcare company that competes in the pharmaceuticals and health sectors, overlapping with Kalbe Farma's market.
GSK
GSK
Mkt Cap107.47B
GlaxoSmithKline is a global healthcare company, competing in pharmaceuticals, vaccines, and consumer healthcare, similar to Kalbe Farma's operations.
Novo Nordisk
NVO
Mkt Cap223.19B
Novo Nordisk is a global healthcare company with a focus on diabetes care, obesity, and other chronic diseases, competing in similar healthcare sectors.
Abbvie
ABBV
Mkt Cap461.26B
AbbVie is a global, research-driven biopharmaceutical company, competing in the development of advanced medical treatments similar to Kalbe Farma's focus.

About

PT Kalbe Farma Tbk is engaged in the development, distribution, and trading of pharmaceutical products. It operates through the following divisions: Prescription Pharmaceutical, Consumer Health, Nutritionals, and Distribution and Logistic. The Prescription Pharmaceutical division offers generic drugs, branded generics, and licensed drugs, which are distributed to hospitals, pharmacies, and drug stores. The Consumer Health division includes over-the-counter drugs, consumer products, food supplements, preventive products, energy drinks, and healthy ready-to-drink products. The Nutritionals division sells biscuits, cereals, and milk products for infants, toddlers, children, pre-teenagers, adults, expectant and lactating mothers, and elderly; as well as nutritional products for consumers with special medical needs. The Distribution and Logistic division maintains distribution of the company's and third party principal's products across Indonesia; and focuses on the trading of raw material, medical devices, and retail health service. The company founded by Boenyamin Setiawan on September 10, 1966 and is headquartered in Jakarta, Indonesia.
Show more...
CEO
Ms. Bernadette Ruth Irawati Setiady MSc.
Employees
12835
Country
Indonesia
ISIN
US69368A1088

Listings

MU
DE
LCLA.MU
STU
DE
LCLA.STU
OTC Link
US
PTKFY
OTC Link
US
PTKFF

0 Comments

Share your thoughts

FAQ

What is Kalbe Farma Tbk PT stock price today?▼
The current price of PTKFY is $8.69 USD — it has increased by +0% in the past 24 hours. Watch Kalbe Farma Tbk PT stock price performance more closely on the chart.
What is Kalbe Farma Tbk PT stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Kalbe Farma Tbk PT stocks are traded under the ticker PTKFY.
Is Kalbe Farma Tbk PT stock price growing?▼
PTKFY stock has risen by +4.7% compared to the previous week, the month change is a +1.33% rise, over the last year Kalbe Farma Tbk PT has showed a -52.9% decrease.
What is Kalbe Farma Tbk PT market cap?▼
Today Kalbe Farma Tbk PT has the market capitalization of 406.81B
When is the next Kalbe Farma Tbk PT earnings date?▼
Kalbe Farma Tbk PT is going to release the next earnings report on July 24, 2026.
What were Kalbe Farma Tbk PT earnings last quarter?▼
PTKFY earnings for the last quarter are 0 USD per share, whereas the estimation was 0 USD resulting in a -5.21% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Kalbe Farma Tbk PT revenue for the last year?▼
Kalbe Farma Tbk PT revenue for the last year amounts to 4.06B USD.
What is Kalbe Farma Tbk PT net income for the last year?▼
PTKFY net income for the last year is 402.77M USD.
Does Kalbe Farma Tbk PT pay dividends?▼
Yes, PTKFY dividends are paid annual. The last dividend per share was 0.44 USD. As of today, Dividend Yield (FWD)% is 2.56%.
How many employees does Kalbe Farma Tbk PT have?▼
As of July 12, 2026, the company has 12,835 employees.
In which sector is Kalbe Farma Tbk PT located?▼
Kalbe Farma Tbk PT operates in the Health & Wellness sector.
When did Kalbe Farma Tbk PT complete a stock split?▼
The last stock split for Kalbe Farma Tbk PT was on October 25, 2012 with a ratio of 5:1.
Where is Kalbe Farma Tbk PT headquartered?▼
Kalbe Farma Tbk PT is headquartered in Jakarta, Indonesia.